← Leaderboards
Patricia J Keely
University Of Wisconsin Madison
$12,114,445
Attributed
$17,210,660
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–16$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$21,105,426 · 16
By mechanism
R01$11,332,765 · 8
U54$5,024,574 · 2
U01$2,297,361 · 1
R21$1,076,005 · 3
T32$1,060,615 · 1
R29$314,106 · 1
Top collaborators
- Julio A Aguirre-Ghiso7 shared
- James Castracane7 shared
- John S Condeelis7 shared
- Vladislav Verkhusha7 shared
- Alissa M Weaver6 shared
- Paul J. Campagnola5 shared
- Yi Jiang5 shared
- Linda A. Schuler5 shared
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Daniel S Greenspan$10,082,953
Others in their field
Top investigators on “Collagen”
- Gary K Owens · University Of Virginia$22,073,978
- Billy Gerald Hudson · Vanderbilt University Medical Center$19,036,330
- Ravinder R Regatte · New York University School Of Medicine$18,437,784
- Brendan Hl Lee · Baylor College Of Medicine$16,945,312
- David E Harrison · Jackson Laboratory$16,731,987
- J. Edwin Blalock · University Of Alabama At Birmingham$16,139,060
Research focus
CollagenExtracellular MatrixSignal TransductionIn VivoTumor ProgressionCellsTumorDensityNeoplasm MetastasisMalignant Breast NeoplasmEnvironmentMammary GlandCarcinomaMammary NeoplasmsTissuesBreastRegulationBaseCell BehaviorDepositionMolecularIn VitroNeoplastic CellMouse Model
Grant awards (61)
An automated high-throughput tissue model for screening metastatic effectors$625,580
R01 · FY2016 · CA
Exosome secretion in breast cancer progression$467,195
R01 · FY2016 · CA
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$465,245
R01 · FY2016 · CA
Mechanisms Of Cell Migration On 3D Aligned Matrices$369,774
R01 · FY2016 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$62,410
R01 · FY2016 · CA
An automated high-throughput tissue model for screening metastatic effectors$610,473
R01 · FY2015 · CA
Collagen structural changes as an early biomarker for breast carcinoma$505,303
R01 · FY2015 · CA · contact PI
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$480,984
R01 · FY2015 · CA
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$461,853
U01 · FY2015 · CA
Tumor microenvironments determing migration, dissemination and dormancy$426,161
U54 · FY2015 · CA
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy$285,291
U54 · FY2015 · CA · contact PI
Tumor microenvironments determing migration, dissemination and dormancy$54,254
U54 · FY2015 · CA
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$36,265
R01 · FY2015 · CA
Tumor microenvironments determing migration, dissemination and dormancy$20,366
U54 · FY2015 · CA
Tumor microenvironments determing migration, dissemination and dormancy$862,508
U54 · FY2014 · CA
Matrix density promotes pro-tumorigenc hormone actions in breast cancer$480,984
R01 · FY2014 · CA
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$447,999
U01 · FY2014 · CA
Mechanisms by which matrix stiffness regulates Rho$286,896
R01 · FY2014 · CA · contact PI
Biophysical Regulation of Breast Differentiation$286,896
R01 · FY2014 · CA · contact PI
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy$286,631
U54 · FY2014 · CA · contact PI
Use of antifibronectin agents to target fibrosis in mammary cancer$190,510
R21 · FY2014 · CA · contact PI
Mechanisms by which matrix stiffness regulates Rho$57,530
R01 · FY2014 · CA · contact PI
Tumor microenvironments determing migration, dissemination and dormancy$908,453
U54 · FY2013 · CA
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$434,144
U01 · FY2013 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$431,674
R01 · FY2013 · CA · contact PI
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy$300,315
U54 · FY2013 · CA · contact PI
Biophysical Regulation of Breast Differentiation$278,023
R01 · FY2013 · CA · contact PI
Mechanisms by which matrix stiffness regulates Rho$278,023
R01 · FY2013 · CA · contact PI
Use of antifibronectin agents to target fibrosis in mammary cancer$163,669
R21 · FY2013 · CA · contact PI
Mechanisms by which matrix stiffness regulates Rho$55,752
R01 · FY2013 · CA · contact PI
Tumor microenvironments determing migration, dissemination and dormancy$784,552
U54 · FY2012 · CA
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$461,853
U01 · FY2012 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$459,893
R01 · FY2012 · CA · contact PI
Graduate Training in Molecular and Cellular Pharmacology$357,236
T32 · FY2012 · GM · contact PI
Mechanisms by which matrix stiffness regulates Rho$295,769
R01 · FY2012 · CA · contact PI
Biophysical Regulation of Breast Differentiation$295,769
R01 · FY2012 · CA · contact PI
ECM Stiffness as a Regulator of Tumor Cell Dissemination and Dormancy$257,571
U54 · FY2012 · CA · contact PI
Mechanisms by which matrix stiffness regulates Rho$19,578
R01 · FY2012 · CA · contact PI
Tumor microenvironments determing migration, dissemination and dormancy$838,472
U54 · FY2011 · CA
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$491,512
U01 · FY2011 · CA
Development of The Prairie Technologies MPLSM to image cancer models in vivo$477,427
R01 · FY2011 · CA · contact PI
Graduate Training in Molecular and Cellular Pharmacology$353,504
T32 · FY2011 · GM · contact PI
Biophysical Regulation of Breast Differentiation$295,769
R01 · FY2011 · CA · contact PI
Mechanisms by which matrix stiffness regulates Rho$295,769
R01 · FY2011 · CA · contact PI
Development of The Prairie Technologies MPLSM to image cancer models in vivo$494,615
R01 · FY2010 · CA · contact PI
Graduate Training in Molecular and Cellular Pharmacology$349,875
T32 · FY2010 · GM · contact PI
Biophysical Regulation of Breast Differentiation$304,917
R01 · FY2010 · CA · contact PI
Mechanisms by which matrix stiffness regulates Rho$304,917
R01 · FY2010 · CA · contact PI
Spectral/FLIM strategies for FRET based analysis of signal transduction pathways$216,681
R21 · FY2010 · EB · contact PI
Development of The Prairie Technologies MPLSM to image cancer models in vivo$518,536
R01 · FY2009 · CA · contact PI
Spectral/FLIM strategies for FRET based analysis of signal transduction pathways$181,745
R21 · FY2009 · EB · contact PI
Using New Optical Techniques to Study Cell Signaling in 3D Matrices$176,400
R21 · FY2009 · CA · contact PI
Using New Optical Techniques to Study Cell Signaling in 3D Matrices$147,000
R21 · FY2008 · CA · contact PI
R-Ras and Integrin Signaling in Breast Cell Phenotype$287,222
R01 · FY2007 · CA · contact PI
R-Ras and Integrin Signaling in Breast Cell Phenotype$295,938
R01 · FY2006 · CA · contact PI
R-Ras and Integrin Signaling in Breast Cell Phenotype$414,818
R01 · FY2005 · CA
R-Ras and Integrin Signaling in Breast Cell Phenotype$414,950
R01 · FY2004 · CA
R-Ras and Integrin Signaling in Breast Cell Phenotype$377,871
R01 · FY2003 · CA
CDC42 AND INTEGRIN SIGNALING IN MAMMARY CELL PHENOTYPE$108,834
R29 · FY2002 · CA
CDC42 AND INTEGRIN SIGNALING IN MAMMARY CELL PHENOTYPE$104,649
R29 · FY2001 · CA
CDC42 AND INTEGRIN SIGNALING IN MAMMARY CELL PHENOTYPE$100,623
R29 · FY2000 · CA